ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $561 | -90.2% | 31,213 | -88.9% | 0.00% | -100.0% |
Q2 2023 | $5,721 | +12.2% | 281,620 | +0.7% | 0.00% | 0.0% |
Q1 2023 | $5,100 | -51.2% | 279,530 | -44.7% | 0.00% | -50.0% |
Q4 2022 | $10,458 | -98.3% | 505,747 | +2016.2% | 0.00% | – |
Q3 2022 | $626,000 | +39.4% | 23,899 | +35.0% | 0.00% | – |
Q2 2022 | $449,000 | -26.8% | 17,701 | -8.9% | 0.00% | – |
Q1 2022 | $613,000 | -15.0% | 19,437 | +9.1% | 0.00% | – |
Q4 2021 | $721,000 | +11.3% | 17,815 | -4.1% | 0.00% | – |
Q3 2021 | $648,000 | +26.8% | 18,584 | -0.2% | 0.00% | – |
Q2 2021 | $511,000 | -14.3% | 18,623 | -12.3% | 0.00% | – |
Q1 2021 | $596,000 | +8.2% | 21,235 | -0.0% | 0.00% | – |
Q4 2020 | $551,000 | +182.6% | 21,244 | +86.3% | 0.00% | – |
Q3 2020 | $195,000 | -95.3% | 11,402 | -97.1% | 0.00% | -100.0% |
Q4 2018 | $4,171,000 | -23.0% | 387,312 | -0.3% | 0.00% | 0.0% |
Q3 2018 | $5,414,000 | -31.3% | 388,390 | -39.7% | 0.00% | 0.0% |
Q2 2018 | $7,884,000 | -22.1% | 644,090 | -1.7% | 0.00% | -50.0% |
Q1 2018 | $10,120,000 | – | 655,438 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |